Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;35(1):81-90.
doi: 10.1097/QAD.0000000000002718.

Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs

Ricky Hsu  1   2 , Laurence Brunet  3 , Jennifer S Fusco  3 , Karam Mounzer  4 , Vani Vannappagari  5 , Cassidy E Henegar  5 , Jean Van Wyk  6 , Lloyd Curtis  7 , Janet Lo  8 , Gregory P Fusco  3
Affiliations

Incident type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs

Ricky Hsu et al. AIDS. .

Abstract

Objectives: To describe the prevalence and incidence of prediabetes and type 2 diabetes mellitus (T2DM) among people living with HIV (PLHIV) and evaluate the association between antiretroviral therapy (ART) initiation with dolutegravir (DTG), elvitegravir/cobicistat (EVG/c), raltegravir (RAL), or boosted darunavir (bDRV) and incident T2DM.

Design: Longitudinal study based on electronic health records of 29 674 PLHIV from the Observational Pharmaco-Epidemiology Research and Analysis (OPERA) cohort.

Methods: Calculate prevalence of prediabetes and T2DM at regimen initiation. Among PLHIV without prevalent disease, estimate prediabetes and T2DM incidence (Poisson regression) and association between regimen and incident T2DM (multivariate Cox proportional hazards regression). Analyses stratified by ART experience.

Results: Among ART-naive and ART-experienced/suppressed PLHIV, the estimated prevalence of prediabetes was 8 and 11%; that of T2DM was 4 and 10%, respectively. The T2DM incidence rate was 9 per 1000 person-years [95% confidence interval (CI): 8-11] among ART-naive and 13 per 1000 person-years (95% CI: 12-15) among ART-experienced/suppressed PLHIV, with no statistically significant differences between regimens. Compared with DTG, no statistically significant association between T2DM risk and regimen was observed among ART-naive on EVG/c [adjusted hazard ratios: 0.70 (95% CI: 0.47-1.05)] or bDRV [0.53 (0.26-1.04)] and ART-experienced/suppressed on EVG/c [0.96 (0.70-1.33)], RAL [1.17 (0.70-1.96)] or bDRV [0.90 (0.57-1.42)].

Conclusion: No increased risk of T2DM was observed with EVG/c, RAL or bDRV compared with DTG in ART-naive and experienced PLHIV. However, despite a large cohort, there was a small number of events and differential risk cannot be excluded.

PubMed Disclaimer

References

    1. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada . PLoS One 2013; 8:e81355.
    1. Wing EJ. HIV and aging . Int J Infect Dis 2016; 53:61–68.
    1. Arafath S, Campbell T, Yusuff J, Sharma R. Prevalence of and risk factors for prediabetes in patients infected with HIV . Diabetes Spectr 2018; 31:139–143.
    1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Edited by Centers for Disease Control and Prevention. Atlanta, GA: US Dept of Health and Human Services; 2017.
    1. Polsky S, Floris-Moore M, Schoenbaum EE, Klein RS, Arnsten JH, Howard AA. Incident hyperglycaemia among older adults with or at-risk for HIV infection . Antivir Ther 2011; 16:181–188.

Publication types

MeSH terms

Substances

LinkOut - more resources